These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12587379)

  • 1. [Principal therapeutic uses of monoclonal antibodies in oncology].
    Penault-Llorca F; Etessami A; Bourhis J
    Cancer Radiother; 2002 Nov; 6 Suppl 1():24s-28s. PubMed ID: 12587379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-cancer monoclonal antibody].
    Sasaki S; Ishida T; Tsujisaki M; Imai K
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():608-12. PubMed ID: 15861718
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined anti-EGFR and anti-HER2 monoclonal antibodies: preclinical efficacy in the treatment of pancreatic cancer].
    Larbouret C; Robert B; Teulon I; Azria D; Pèlegrin A
    Med Sci (Paris); 2007 Oct; 23(10):800-3. PubMed ID: 17937885
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody therapy of lymphoma.
    Illidge TM; Bayne MC
    Expert Opin Pharmacother; 2001 Jun; 2(6):953-61. PubMed ID: 11585011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial growth factor receptor interacting agents.
    Baselga J; Albanell J
    Hematol Oncol Clin North Am; 2002 Oct; 16(5):1041-63. PubMed ID: 12512382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticles.
    Cirstoiu-Hapca A; Bossy-Nobs L; Buchegger F; Gurny R; Delie F
    Int J Pharm; 2007 Mar; 331(2):190-6. PubMed ID: 17196347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse effects of the humanized antibodies used as cancer therapeutics.
    Klastersky J
    Curr Opin Oncol; 2006 Jul; 18(4):316-20. PubMed ID: 16721123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular and cellular biology of HER2/neu gene amplification/overexpression and the clinical development of herceptin (trastuzumab) therapy for breast cancer.
    Pegram MD; Konecny G; Slamon DJ
    Cancer Treat Res; 2000; 103():57-75. PubMed ID: 10948442
    [No Abstract]   [Full Text] [Related]  

  • 9. V gamma 9 V delta 2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs--rituximab and trastuzumab.
    Tokuyama H; Hagi T; Mattarollo SR; Morley J; Wang Q; So HF; Moriyasu F; Nieda M; Nicol AJ
    Int J Cancer; 2008 Jun; 122(11):2526-34. PubMed ID: 18307255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies as therapeutic agents for cancer.
    Harris M
    Lancet Oncol; 2004 May; 5(5):292-302. PubMed ID: 15120666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of rituximab, trastuzumab, cetuximab, or mAb T101 to cancer cells promotes trogocytosis mediated by THP-1 cells and monocytes.
    Beum PV; Mack DA; Pawluczkowycz AW; Lindorfer MA; Taylor RP
    J Immunol; 2008 Dec; 181(11):8120-32. PubMed ID: 19018005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies in the treatment of cancer, Part 1.
    Cersosimo RJ
    Am J Health Syst Pharm; 2003 Aug; 60(15):1531-48. PubMed ID: 12951753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monoclonal antibody treatment of malignant lymphoma].
    Buske C; Dreyling M; Unterhalt M; Hiddemann W
    Internist (Berl); 2004 Dec; 45(12):1370-7. PubMed ID: 15517123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody therapy.
    O'Mahony D; Bishop MR
    Front Biosci; 2006 May; 11():1620-35. PubMed ID: 16368542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the efficacy of antibody-based cancer therapies.
    Carter P
    Nat Rev Cancer; 2001 Nov; 1(2):118-29. PubMed ID: 11905803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman RA
    Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monoclonal antibody therapy: a literature review].
    Del Debbio CB; Tonon LM; Secoli SR
    Rev Gaucha Enferm; 2007 Mar; 28(1):133-42. PubMed ID: 17658067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody therapy in lymphoid malignancies.
    Hainsworth JD
    Oncologist; 2000; 5(5):376-84. PubMed ID: 11040273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New antibodies in cancer treatment].
    Pestalozzi BC; Knuth A
    Praxis (Bern 1994); 2004 Sep; 93(39):1589-92. PubMed ID: 15500243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoclonal antibody for cancer treatment].
    Achiwa H; Sato S; Ueda R
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):495-501. PubMed ID: 11977531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.